If a variant has more than one submission, it may be counted in more than one significance column. If this is the case, the total number of variants will be less than the sum of the other cells.
| pathogenic | likely pathogenic | uncertain significance | likely benign | benign | total |
|---|---|---|---|---|---|
| 14 | 291 | 0 | 0 | 0 | 305 |
Gene and significance breakdown #
Total genes and gene combinations: 35
| Gene or gene combination | pathogenic | likely pathogenic | total |
|---|---|---|---|
| TP53 | 0 | 108 | 108 |
| PIK3CA | 0 | 49 | 49 |
| CTNNB1, LOC126806658 | 0 | 28 | 28 |
| FBXW7 | 0 | 15 | 15 |
| NRAS | 0 | 11 | 11 |
| HRAS, LRRC56 | 0 | 10 | 10 |
| FGFR2 | 0 | 8 | 8 |
| ERBB2 | 0 | 6 | 6 |
| PTEN | 0 | 6 | 6 |
| ERBB3 | 0 | 5 | 5 |
| MTOR | 0 | 5 | 5 |
| PPP2R1A | 0 | 5 | 5 |
| MSH6 | 3 | 1 | 4 |
| NFE2L2 | 0 | 4 | 4 |
| POLE | 0 | 4 | 4 |
| SPOP | 0 | 4 | 4 |
| BRAF | 0 | 3 | 3 |
| BRCA2 | 3 | 0 | 3 |
| MAP2K1 | 0 | 3 | 3 |
| MSH2 | 2 | 1 | 3 |
| RAC1 | 0 | 3 | 3 |
| XPO1 | 0 | 3 | 3 |
| RHEB | 0 | 2 | 2 |
| U2AF1 | 0 | 2 | 2 |
| ATM | 1 | 0 | 1 |
| ATM, C11orf65 | 1 | 0 | 1 |
| BRCA1 | 1 | 0 | 1 |
| BRIP1 | 1 | 0 | 1 |
| CHEK2 | 1 | 0 | 1 |
| KRAS | 0 | 1 | 1 |
| MYCN, MYCNOS | 0 | 1 | 1 |
| PALB2 | 1 | 0 | 1 |
| PIK3R1 | 0 | 1 | 1 |
| RAD51C | 0 | 1 | 1 |
| SOS1 | 0 | 1 | 1 |
Submitter and significance breakdown #
Total submitters: 4
| Submitter | pathogenic | likely pathogenic | total |
|---|---|---|---|
| Database of Curated Mutations (DoCM) | 0 | 287 | 287 |
| CZECANCA consortium | 12 | 3 | 15 |
| Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen | 1 | 1 | 2 |
| University Health Network, Princess Margaret Cancer Centre | 1 | 0 | 1 |